Navigation Links
Elbit Imaging Ltd. Announces Second Quarter Results for 2011
Date:8/31/2011

looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.

 


 

ELBIT IMAGING LTD.

CONSOLIDATED BALANCE SHEETS

December June 30 31, June 30 2011 2010 2010 2011 (in thousand NIS) Convenience translation US$'000 Current Assets Cash and cash equivalents 962,286 1,189,351 1,040,797 281,782 Short-term deposits and investments 901,225 637,264 835,730 263,902 Trade accounts receivable 56,001 80,336 55,084 16,399 Other receivable 217,099 156,827 108,940 63,572 Prepayments and other assets 279,805 316,792 295,305 81,934 Inventories 50,836 54,542 44,643 14,886 Trading property 4,505,162 4,119,239 4,192,241 1,319,227 6,972,414 6,554,351 6,572,740 2,041,702 Assets related to discontinued operation - 2,244 - - 6,972,414 6,445,595 6,572,740 2,041,702 Non-Current Assets Deposits, loans and other long-term balances 609,702 624,542 645,842 178,536 Investments in associates 12,535 37,894 25,127 3,671 Property, plant and equipment 1,188,382 1,626,620 1,157,206 347,989 Investment property 2,214,860 2,472,472 2,232,322 648,568 Other assets and deferred expenses 24,725 25,990 21,160 7,240 Intangible assets 73,817 51,248 48,316 21,616 4,124,021 4,338,766 4,129,973 1,207,620 11,096,435 11,395,361 10,702,713 3,249,322 Current Liabilities Short-term credits 2,175,214 2,578,457 2,446,546 636,959 Suppliers and service providers 124,898 152,468 109,426 36,573 Payables and other credit balances 247,914 342,928 196,445 72,596 Other liabilities 140,320 114,976 126,590 41,089 2,688,346 3,188,829 2,879,007 787,217 Liabilities related to discontinued operation 11,956 19,106 12,615 3,501 2,700,302 3,207,935 2,891,622 790,718 Non-Current liabilities Borrowings 6,144,589 5,924,770 5,524,260 1,799,294 Other financial liabilities 77,819 34,021 75,532 22,787 Other liabilities 14,727 17,277 14,005 4,312 Deferred taxes 28,256 26,646 19,773
'/>"/>

SOURCE Elbit Imaging Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Elbit Imaging Ltd. Announces Interest Rate for the Next Interest Period for Series B Notes
2. Elbit Imaging Announces Share Purchase Agreement With Enter Holdings
3. Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials
4. Elbit Imaging Ltd. Announces First Quarter Results for 2010
5. Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma
6. Elbit Imaging Announces InSightecs First Non-Invasive Technology for Treatment of Uterine Fibroids Awarded MHLW Approval in Japan
7. Elbit Imaging Ltd. Announces Sale of Plaza Centers Shares
8. Elbit Imaging Ltd. Announces - Swiss Team Uses InSightecs ExAblate(R) 4000 Brain System to Treat Patients With Functional Brain Disorders
9. Pathologists Gather to Focus on Advances in Molecular Testing, Digital Imaging, and Biospecimens
10. Strategic Assessments of Leading North American Diagnostic Imaging Market Players
11. MarketsandMarkets: "Radiopharmaceuticals for Therapy and PET/SPECT Imaging" Market to reach $4,734 Million by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... THOUSAND OAKS, Calif. , May 22, ... today announced the Company has commenced termination ... commercialization of brodalumab with AstraZeneca (LON:AZN, STO:AZN ... investigational IL-17 inhibitor, is in development for ... and axial spondyloarthritis.  The decision was based ...
(Date:5/22/2015)... 22, 2015  Effective staffing of key marketing ... and success. Research and consulting ... provide pharmaceutical and biotech marketing managers with metrics ... that are being channeled into marketing operations of ... can utilize this report to benchmark their own ...
(Date:5/22/2015)... Electrophysiologist Kevin Makati, M.D. with St. ... Boston, MA to speak about ... Society conference. These scientific sessions drew more than ... people and technology that propel their specialty forward. ... invasive cardiac operation that combines the expertise of ...
Breaking Medicine Technology:Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3
... patients achieve undetectable HCV RNA levels following 4 weeks of ... and tolerability comparable to placebo administered with Pegasys ... ... VRUS ) announces the preliminary results of the third cohort of a,4-week ...
... achieved SVR 12 with 48-week boceprevir-based ... combination therapy ... arm, KENILWORTH, N.J., Aug. 4 Schering-Plough,Corporation (NYSE: SGP ) ... study of boceprevir, its investigational,oral hepatitis C protease inhibitor. The analysis showed ...
Cached Medicine Technology:Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 2Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 3Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 4Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 5Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 2Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 3Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 4Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 5Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 6Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 7Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 8Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 9
(Date:5/22/2015)... Combination therapy, or polytherapy, will ... obstructive pulmonary disorder (COPD) as the dominant companies ... as well as Germany’s Boehringer Ingelheim compete with ... will market payers, clinicians and patients be disposed ... completely new ones? , In spite of recently ...
(Date:5/22/2015)... May 22, 2015 “It’s like ... SLP, RAC-CT, CHHRP-QT, Vice President of Clinical Operations/Education ... important ‘language’ that impacts how care is coded ... in long term care reimbursement, operations and compliance ... and talent management, launches a new series of ...
(Date:5/22/2015)... 2015 Carnegie Science Center ... a new partnership to develop BodyTech, a dynamic, three-pronged ... initiative includes a new exhibit at the Science Center ... and a new traveling science show, Anatomy Adventure, which ... , Designed to explore a wide range of ...
(Date:5/22/2015)... 22, 2015 Memorial Day weekend is typically ... is offering some tips to help promote safe travel. ... will be 383 traffic fatalities this Memorial Day weekend. Amica ... Highway Traffic Safety Association: , , ... is wearing a seatbelt, whether they’re driving or riding along ...
(Date:5/22/2015)... 2015 Power Systems is proud to announce ... race season. Drobeck is in his second year of racing ... with the Missoula Fire Department in Missoula, MT. He entered ... 2014. During his career, he has had 15 1st Place ... top 10 finishes in all seven of his 2014 races, ...
Breaking Medicine News(10 mins):Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2
... Reading a book can satisfy the crucial human need for ... 140 university students who were given 30 minutes to read ... Twilight or the wizard novel Harry Potter and ... of either vampires or wizards. The participants were then ...
... rising levels of cardiovascular disease (CVD) in the Asia Pacific ... the first time- the Society will send an official delegation ... The 18th edition of the APCC meeting will be ... 2011. The ESC deputation will present an educational programme called ...
... Chief of both the Division of Allergy and Inflammation and ... Center (BIDMC), is the recipient of an NIH MERIT ... A Professor of Medicine at Harvard Medical School, Weller received ... Functioning." An acronym for the Method to Extend Research ...
... is regarded as the most thorough way to ... procedure can also be painful. Scientists and engineers ... reduce patient discomfort while also ensuring the accuracy ... of Engineering led by Associate Professor of Mechanical ...
... accepted for publication in The Endocrine Society,s Journal of ... and white children with vitamin D deficiency both had higher ... levels of fat just under their skin and white children ... their internal organs. Studies in adults and children have ...
... The Scripps Research Institute and Tampa,s Moffitt Cancer ... study the formation and progression of prostate cancer. Of ... Scripps Research, with the remaining $138,380 supporting Moffitt Cancer ... Institutes of Health (NIH) will fund research to advance ...
Cached Medicine News:Health News:The European Society of Cardiology organizes educational program in Asia 2Health News:BIDMC's Peter Weller, M.D., receives NIH MERIT Award 2Health News:A less painful colonoscopy 2Health News:A less painful colonoscopy 3Health News:Vitamin D deficiency is associated with different types of obesity in black and white children 2Health News:Scripps Research wins more than $2 million to study prostate cancer 2
... nRBC-Chex for LH is a nucleated red blood ... precision of the Coulter LH 750/LH 755 hematology ... The assay provides for the Coulter LH 750/LH ... packaged in plastic, cap-pierceable vials. nRBC-Chex for LH ...
Indicated to facilitate the intra-luminal placement of conventional guidewires beyond stenotic lesions, including chronic total coronary occlusions....
... 12 Extend is a three-part differential control assayed ... STKR, J Series, T Series, AcT/AcT diff/AcT diff2, ... 1500, 1600, 1700, and 1800; ABX Micros 60; ... Extend has an open-vial stability of 30 days ...
... 5-part differential control that controls all parameters, ... LH 750/LH 755, MAXM and HmX instruments. ... values for all three levels. White blood ... are within clinically significant ranges. This unique ...
Medicine Products: